CooperVision Expands Parameters for Avaira Toric CLs

Starting this month, CooperVision Inc. is expanding its parameters for its Avaira toric contact lenses with new +0.25D to +6.00D sphere powers to correct for hyperopia. A 2011 study indicated that 15.7 percent of hyperopes were also astigmatic. These new options join the existing parameter range, including sphere powers of plano to -6.00D in 0.25 steps; -6.50D to -10.00D in 0.50 steps; cylinder powers of -0.75, -1.25, and -1.75; and axes from 10 degrees to 180 degrees in 10 degree steps. Read more.;

Biofinity Said to Be Fastest Growing CL Brand

CooperVision claims that Biofinity brand was the fastest growing contact lens brand in the U.S. between April 2012 and March 2013. The number of new Biofinity patients reportedly grew faster than any other frequent-replacement contact lens brand. The company says that its Biofinity combines a high oxygen permeability (Dk128) and high water content (H₂O 48 percent), making for a more flexible lens (modulus 0.75 MPa). Read more.

Securities Firm Looks into Fraud at Cooper

The securities firm Faruqi & Faruqi, LLP, is investigating whether Cooper and its officers violated federal securities laws by failing to disclose what a Faruqi press release called "the true significance of its product recall." In August 2011, the company commenced a “limited voluntary” recall of its Avaira Toric line of contact lenses. Faruqi's press release stated that at that time, Cooper intentionally downplayed the breadth and impact of its quality control problems. On November 15, 2011, Cooper expanded its recall. Shortly thereaftrer, the company’s stock price fell. Request more information now by clicking here: www.faruqilaw.com/COO.

The Cleveland.InjuryBoard.com reports that "as the recall of Avaira contact lenses has been expanded, reports of adverse symptoms have also increased. Individuals who used Avaira Toric or Avaira Sphere contact lenses continue to report adverse events to CooperVision, as well as to their doctors, lawyers, and the FDA. There are increasing reports of serious eye injuries including corneal ulcers, corneal lesions, corneal abrasions, corneal edema, corneal erosion, and keratitis." Read more.

Cooper Expands the Avaira Recall -- Again

"Cooper Cos. has broadened a contact lens recall to include some lots of its Avaira Sphere lenses and expects a roughly $9 million charge in its fiscal fourth quarter," reports the WSJ's MarketWatch. "Cooper in August issued a recall for some lots of its Avaira Toric contact lenses after a small number of customers complained of hazy vision after wearing them. The company's CooperVision unit said it identified a residue on a small number of the lenses, which were first introduced in April 2010. Tuesday, the company said it was expanding its recall as certain lots of Avaira Sphere lenses failed to meet updated quality requirements due to the level of a silicone oil residue. The company said no other product line uses silicone oil in the manufacturing process other than Avaira Sphere and Avaira Toric." Read more.


According to the company's press release, "CooperVision announced today that it is expanding its worldwide recall of the encore 100 brand product line of contact lenses to include a limited number of lots of encore100 Sphere contact lenses. In continued collaboration with the United States Food and Drug Administration and Health Canada, CooperVision is expanding the recall because it identified certain lots of encore100 Sphere lenses that did not meet its updated quality requirements due to the level of a silicone oil residue."